( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive results from the FB102 double-blind placebo-controlled ...

Phase transformations—in which a material changes from one crystal structure to another, thereby acquiring dramatically ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological disorders, today announced ...

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

A newly found chain-reaction phase change in 2D MoTe2 lowers energy barriers, enabling faster control of electronic and ...

Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...

When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...

PETERSBURG, FL – Water Tower Research ( has published an Initiation of Coverage Report on Solvonis Therapeutics PLC (LSE: SVNS) titled, “Pursuing Acute Intervention Rather Than Chronic Treatment of ...

Tvardi Therapeutics TVRD stock has skyrocketed 148.8% so far this week, reflecting strong investor enthusiasm following a ...

FDA Drug Approvals and Regulatory Updates Drug Pharmacologic class Indication More information Cardiovascular Disease Tryngolza (olezarsen) Apolipoprotein ...

Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...